Lakewood-Amedex
Our novel approach fights infections with highly effective Bisphosphocins® directly at the site of infection.
Series B+ ·
Amount not disclosed in a source on record.
Funding history ↓Signals
Website registeredOct 1, 2007 (19 years old)
About Lakewood-Amedex
Bisphosphocins® directly disrupt microbial membranes, leading to fast eradication of infections.
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Series B+ | undisclosed | — | fundraisingfox.com |
Timeline
- Website created
Companies like Lakewood-Amedex
AAppend Medical$4.35M Series A · Jul 2023QQuanta TherapeuticsSeries B+ · Oct 2026
CCBioSeedZZymofix$6.76M Series A · Sep 2026
FF2G$100M Series B+ · Sep 2024
ZZonovaSeed · May 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/lakewood-amedex (get a free API key).